Literature DB >> 9219567

Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines.

R E Rasmussen1, D B Menzel.   

Abstract

This study was undertaken to compare the genotoxic effects of arsenite in cultured human lymphocytes and lymphoblastoid cell lines from a group of normal human volunteers. The goal was to determine whether, as found with other genotoxins, subgroups might exist which showed relative high or low sensitivity to induction of sister chromatid exchanges (SCEs) by this metal. Primary lymphoblast cultures were established by treatment with phytohemagglutinin (PHA-L). Lymphoblastoid cell lines were established by transformation with Epstein-Barr virus. Cultures were exposed for 40 h to sodium arsenite (AsIII) and SCEs assayed by 5-bromo-2'-deoxyuridine incorporation and staining by fluorescence plus Giemsa. SCEs were increased by arsenite in a dose-dependent manner over the concentration range of 10(-7)-10(-5) M. SCEs could not be scored above 10(-5) M because of cytotoxicity. Comparison of SCE frequency in primary lymphocyte cultures among individuals showed substantial variation in sensitivity to arsenite, with some showing no significant effect while others showed a 2-3-fold increase in SCE frequency. In one lymphoblastoid cell line especially sensitive to arsenite, arsenic acid (AsV) or dimethylarsinic acid (DMA) at concentrations up to 10(-5) M did not increase the SCE frequency suggesting that AsIII is the active form of arsenic. When pooled data from the primary lymphocytes was compared to that obtained with the lymphoblastoid cells, the slopes of the dose-response curves for ASIII-induced SCEs were similar. The sensitivity of the majority of the individual primary lymphocyte cultures to SCE induction by arsenite was correlated with the sensitivity of the lymphoblastoid cultures established from the same individual. However, in three individuals no correlation was found. Individual lymphoblastoid cell lines retained their As sensitivity after cryopreservation and subsequent revival. Whether the genotoxic response to As is genetically controlled or the result of phenotypic selection is being explored in these stable lymphoblastoid cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219567     DOI: 10.1016/s1383-5742(97)00010-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241M polymorphism.

Authors:  Manjari Kundu; Pritha Ghosh; Sanhita Mitra; J K Das; T J Sau; Saptarshi Banerjee; J Christopher States; Ashok K Giri
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

2.  Evaluation of the serum catalase and myeloperoxidase activities in chronic arsenic-exposed individuals and concomitant cytogenetic damage.

Authors:  Mayukh Banerjee; Nilanjana Banerjee; Pritha Ghosh; Jayanta K Das; Santanu Basu; Ajoy K Sarkar; J Christopher States; Ashok K Giri
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-20       Impact factor: 4.219

3.  Solar UV radiation enhances the toxicity of arsenic in Ceriodaphnia dubia.

Authors:  Lara J Hansen; J Andrew Whitehead; Susan L Anderson
Journal:  Ecotoxicology       Date:  2002-08       Impact factor: 2.823

4.  Toxicity Screening of Single Dose of Inorganic and Organic Arsenics on Hematological and Serum Biochemical Parameters in Male Cynomolgus Monkeys.

Authors:  Choong-Yong Kim; Kang-Hyun Han; Jeong-Doo Heo; EuiSik Han; YoungNa Yum; Jin-Young Lee; KyungSu Park; Ruth Im; Seong-Jin Choi; Jung-Duck Park
Journal:  Toxicol Res       Date:  2008-09-01

Review 5.  Substantial Evidences Indicate That Inorganic Arsenic Is a Genotoxic Carcinogen: a Review.

Authors:  Jinia Sinha Roy; Debmita Chatterjee; Nandana Das; Ashok K Giri
Journal:  Toxicol Res       Date:  2018-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.